Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00326196 · ClinicalTrials.gov registry record · Phase 4
Coronary Artery Revascularization in Diabetes
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- Phase 4
- Development phase
- 198
- Enrollment target
NCT00326196 is a Phase 4 study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 198 participants.
The verdict
NCT00326196, a Phase 4 study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 198 participants
- Enrollment target
Study Summary
This is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant coronary artery disease in diabetes. The hypothesis being tested is that a strategy of surgical revascularization is superior to percutaneous intervention in preventing death or myocardial infarction in diabetics with severe ischemic heart disease.
Interventions
- DEVICE Percutaneous coronary intervention (PCI)
- PROCEDURE Coronary artery bypass graft (CABG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2006-07 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00326196
The ClinicalTrials.gov registry entry for NCT00326196 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Percutaneous coronary intervention (PCI) is the first listed.
NCT00326196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00326196 about?
NCT00326196 is a clinical study titled "Coronary Artery Revascularization in Diabetes". This is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant coronary artery disease in diabetes. The hypothesis being tested is that a strategy of surgical revascularization is superior t...
What is the current status of trial NCT00326196?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 198 participants. The study started on 2006-07. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00326196?
The interventions under investigation include: Percutaneous coronary intervention (PCI) (DEVICE), Coronary artery bypass graft (CABG) (PROCEDURE).
Who is sponsoring clinical trial NCT00326196?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.